Literature DB >> 8345070

Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage.

H Watson1, D S Kiddy, D Hamilton-Fairley, M J Scanlon, C Barnard, W P Collins, R C Bonney, S Franks.   

Abstract

Polycystic ovary syndrome is associated with hypersecretion of luteinizing hormone (LH) which has been implicated in the aetiology of early pregnancy loss. Although 82% of women with recurrent early loss have polycystic ovaries on ultrasound imaging, random serum LH concentrations are normal. In the present study, we have obtained further information from serial samples concerning the cyclical patterns of gonadotrophin and sex steroid secretion in these women. Twenty-one women with recurrent early pregnancy loss and 10 multiparous controls were investigated; 81% of them and one of ten control subjects had polycystic ovaries. Mean mid-follicular and mid-luteal serum LH and follicle stimulating hormone (FSH) levels were similar in both groups. Seventeen women with pregnancy loss had either raised urinary LH excretion or a premature LH surge; one control subject had a premature LH surge. Total LH excretion during the cycle and mean follicular phase serum testosterone was significantly greater with early pregnancy loss than in the control group, the difference in LH being greatest in the early luteal phase. Urinary oestrone-3-glucuronide excretion was raised in the early luteal phase of the cycle in the group with early pregnancy loss; there was no difference between the groups in pregnanediol-3 alpha-glucuronide excretion. These data demonstrate abnormalities in LH secretion in 81% of women with recurrent fetal loss. Inappropriately raised LH levels may have adverse effects on the developing oocyte or endometrium either directly, or indirectly by causing an elevation in testosterone and oestrogen levels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8345070     DOI: 10.1093/oxfordjournals.humrep.a138149

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  12 in total

1.  Recurrent pregnancy loss: etiology, diagnosis, and therapy.

Authors:  Holly B Ford; Danny J Schust
Journal:  Rev Obstet Gynecol       Date:  2009

Review 2.  The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization.

Authors:  B C Tarlatzis; G Grimbizis
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

3.  Effects of propylene glycol or elevated luteinizing hormone during follicle development on ovulation, fertilization, and early embryo development.

Authors:  Katherine S Hackbart; Robb W Bender; Paulo D Carvalho; Lais M Vieira; Ana R Dresch; Jerry N Guenther; Hidir Gencoglu; Anibal B Nascimento; Randy D Shaver; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2017-10-01       Impact factor: 4.285

4.  Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial.

Authors:  K Clifford; R Rai; H Watson; S Franks; L Regan
Journal:  BMJ       Date:  1996-06-15

5.  Recombinant follitropin alfa/lutropin alfa in fertility treatment.

Authors:  Ahmed Gibreel; Siladitya Bhattacharya
Journal:  Biologics       Date:  2010-02-04

6.  Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.

Authors:  S West; H Lashen; A Bloigu; S Franks; K Puukka; A Ruokonen; M-R Järvelin; J S Tapanainen; L Morin-Papunen
Journal:  Hum Reprod       Date:  2014-08-01       Impact factor: 6.918

7.  Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study.

Authors:  Selda Uysal; Ahmet Zeki Isik; Serenat Eris; Seyran Yigit; Yakup Yalcin; Pelin Ozun Ozbay
Journal:  Obstet Gynecol Int       Date:  2015-02-28

8.  Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review.

Authors:  Bernd Th Krause; Ralf Ohlinger; Annette Haase
Journal:  Biologics       Date:  2009-07-13

9.  The Effect of Ageing on Clinical, Hormonal and Sonographic Features Associated with PCOS-A Long-Term Follow-Up Study.

Authors:  Małgorzata Jacewicz-Święcka; Sławomir Wołczyński; Irina Kowalska
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

10.  Investigation on estrogen receptor alpha gene polymorphisms in Iranian women with recurrent pregnancy loss.

Authors:  Marzieh Mahdavipour; Farah Idali; Saeed Zarei; Saeed Talebi; Ramina Fatemi; Mahmood Jeddi-Tehrani; Somayeh Pahlavan; Farzad Rajaei
Journal:  Iran J Reprod Med       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.